phrykt

CV Sciences, Inc. (CVSI): who owns it and who trades it

As of Nov 16, 2026, CVSI insiders reported 15 purchases worth $169K in the last 12 months. The largest buyer was Charlie E Cheever III (10% owner), with $169K.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, CVSI insiders reported $169K of open-market purchases and $0 of sales.

Purchases, 12 months
$169K
15 trades, 1 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Nov 11, 2026
Filed Nov 16, 2026

Purchases and sales by month

$111K$111KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 11, 2026Charlie E Cheever III10% ownerPurchase383,205$0.01$3.8KForm 4
Nov 9, 2026Charlie E Cheever III10% ownerPurchase1.98M$0.01$19.8KForm 4
Nov 6, 2026Charlie E Cheever III10% ownerPurchase500,000$0.01$5KForm 4
Nov 5, 2026Charlie E Cheever III10% ownerPurchase1.08M$0.01$10.8KForm 4
Nov 4, 2026Charlie E Cheever III10% ownerPurchase1.50M$0.01$15KForm 4
Aug 7, 2026Charlie E Cheever III10% ownerPurchase94,854$0.02$1.9KForm 4
Aug 4, 2026Charlie E Cheever III10% ownerPurchase108,000$0.02$2.2KForm 4
Jul 31, 2026Charlie E Cheever III10% ownerPurchase1.73M$0.02$34.6KForm 4
Jul 29, 2026Charlie E Cheever III10% ownerPurchase60,000$0.02$1.2KForm 4
Jul 28, 2026Charlie E Cheever III10% ownerPurchase1.83M$0.02$36.6KForm 4
Jul 24, 2026Charlie E Cheever III10% ownerPurchase470,075$0.02$9.4KForm 4
Jul 22, 2026Charlie E Cheever III10% ownerPurchase272,500$0.02$5.5KForm 4
Jul 21, 2026Charlie E Cheever III10% ownerPurchase335,000$0.02$6.7KForm 4
Jul 17, 2026Charlie E Cheever III10% ownerPurchase749,000$0.02$15KForm 4
Jul 16, 2026Charlie E Cheever III10% ownerPurchase91,387$0.02$1.8KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Charlie E Cheever III10% owner$169K–Nov 11, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CVSI short interest

Low short interest. Less than 0.1% of CVSI shares are sold short. Over the last 12 reports the number of shares short went down 62%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 6,360 CVSI shares were sold short, 0.0% of the shares outstanding, down 82.7% from the report before. At the average daily volume of 1.09M shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.00%May 15Oct 300.09%

Days to cover

1.0May 15Oct 301.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20266,3600.00%-83%1.09M1.0
Oct 15, 202636,6680.02%+158%349,8971.0
Sep 30, 202614,1900.01%+123%1.84M1.0
Sep 15, 20266,3600.00%-94%883,9781.0
Aug 31, 2026103,4310.05%+63%1.49M1.0
Aug 14, 202663,3180.03%+896%324,2151.0
Jul 31, 20266,3600.00%No change1.42M1.0
Jul 15, 20266,3600.00%-96%1.42M1.0
Jun 30, 2026157,4430.08%+357%2.36M1.0
Jun 15, 202634,4320.02%+441%636,1471.0
May 29, 20266,3600.00%-62%1.12M1.0
May 15, 202616,7000.01%+9%1.34M1.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

CV Sciences company events

CV Sciences filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 26, 2026.

  1. Oct 26, 2026AnnouncementAs previously reported by the Company on February 12, 2025, the Company initiated an arbitration with JAMS against its former legal counsel. Filing
  2. Aug 13, 2026ResultsReleased financial results. Filing
  3. Jun 4, 2026LeadershipThe information contained in Item 5.07 is incorporated by reference herein. Filing
  4. May 14, 2026ResultsReleased financial results. Filing
  5. Apr 10, 2026AgreementAs previously disclosed, on February 12, 2025, CV Sciences, Inc., a Delaware corporation entered into a note purchase agreement with an institutional investor, pursuant to which the Company issued and sold to the Investor a secured promissory note in the original principal amount of $1.6 million. Filing
  6. Mar 26, 2026ResultsReleased financial results. Filing
  7. Mar 10, 2026AgreementAs previously disclosed, on February 12, 2025, CV Sciences, Inc., a Delaware corporation entered into a note purchase agreement with an institutional investor, pursuant to which the Company issued and sold to the Investor a secured promissory note in the original principal amount of $1.6 million. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

CV Sciences financials

Questions about CV Sciences, Inc. (CVSI) stock

Are CVSI insiders buying or selling?

In the last 12 months, CVSI insiders reported 15 open-market purchases worth $169K and no sales. The latest trade was on Nov 11, 2026. See every trade.

What is the short interest in CVSI?

As of Oct 30, 2026, 6,360 CVSI shares were sold short, 0.0% of the shares outstanding, down 82.7% from the report before. At the average daily volume of 1.09M shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Executive pay

CV Sciences's chief executive was paid a total of $419K for the year ended Dec 31, 2025, down 8% from $458K the year before. In the last 12 months, CV Sciences's executives and directors bought no stock on the open market and sold none.

Chief executive, total pay$419KYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$423KThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$308KThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.